Compounds > tirofiban
Page last updated: 2024-08-24

tirofiban and Cerebral Hemorrhage

tirofiban has been researched along with Cerebral Hemorrhage in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.00)29.6817
2010's10 (50.00)24.3611
2020's8 (40.00)2.80

Authors

AuthorsStudies
Chen, X; Feng, Y; Jia, C; Ma, Y; Zhang, T; Zhao, W1
Huang, X; Jiang, Z; Liu, H; Ren, Y; Sun, Y; Wang, L; Zheng, H1
Du, N; Liu, YL; Wang, LX; Yang, L; Yin, XL; Zhao, JS1
Fei, Y; Lin, S; Lin, Y; Pan, X; Xu, M; Yang, J; Zou, J1
Guo, Y; He, C; Shang, X; Yang, K; Zhou, Z; Zi, W1
Guan, Q; Li, J; Li, X; Lv, W; Ni, H; Xie, Z; Xu, Y; Yun, W; Zhang, L; Zhang, Q; Zhou, J1
Tang, L; Tang, X; Yang, Q1
Hadler, F; Nikoubashman, O; Reich, A; Singh, R; Wiesmann, M1
Che, R; Chen, J; Duan, J; Feng, W; Ji, X; Li, C; Liebeskind, D; Ling, F; Shang, S; Song, H; Wang, Y; Wu, C; Wu, L; Zhang, H; Zhao, W1
Feng, W; Huang, SH; Li, W; Li, XS; Liang, CR; Lin, L; Liu, CC; Wang, H; Wang, YJ; Wu, Y; Xu, ZQ; Zhang, LL; Zhang, M1
Gibson, E; Hasan, DM; Jabbour, P; Nakagawa, D; Ortega-Gutierrez, S; Roa, JA; Samaniego, EA; Zanaty, M1
Bendszus, M; Hacke, W; Hametner, C; Kellert, L; Ringleb, P; Rohde, S; Stampfl, S1
Barry, DM; Dai, XR; Fan, ML; Hou, SX; Jin, H; Kong, F; Lau, LF; Li, TT; Li, XY; Luo, SY; Zhang, GH; Zhou, LL1
Bruder, M; El-Fiki, A; Güresir, E; Konczalla, J; Lescher, S; Schuss, P; Seifert, V; Vatter, H1
Cha, JK; Choi, JH; Huh, JT; Kang, M; Kim, S1
Baik, SK; Hwang, JC; Kwon, JH; Shin, SH; Weon, YC1
Chalouhi, N; Hasan, D; Jabbour, P; Kung, D1
Alexandrov, AV; Bavarsad Shahripour, R1
Alexander, KP; Chen, AY; Gibler, WB; Hochman, JS; Newby, LK; Ohman, EM; Peterson, ED; Redberg, RF; Roe, MT; Schwartz, JB1
Aulich, A; Freund, HJ; Junghans, U; Seitz, RJ; Siebler, M1

Reviews

2 review(s) available for tirofiban and Cerebral Hemorrhage

ArticleYear
The Application of Tirofiban in the Endovascular Treatment of Acute Ischemic Stroke: A Meta-Analysis.
    Cerebrovascular diseases (Basel, Switzerland), 2021, Volume: 50, Issue:2

    Topics: Aged; Cerebral Hemorrhage; Endovascular Procedures; Female; Functional Status; Humans; Ischemic Stroke; Male; Middle Aged; Motor Activity; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recovery of Function; Risk Assessment; Risk Factors; Time Factors; Tirofiban; Treatment Outcome

2021
Ancillary approaches to plasminogen activators.
    Annals of the New York Academy of Sciences, 2012, Volume: 1268

    Topics: Anticoagulants; Arginine; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Collateral Circulation; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypothermia, Induced; Low-Level Light Therapy; Pipecolic Acids; Plasminogen Activators; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy; Vasodilator Agents

2012

Trials

2 trial(s) available for tirofiban and Cerebral Hemorrhage

ArticleYear
Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms.
    Neurosurgery, 2012, Volume: 71, Issue:3

    Topics: Adult; Aged; Cerebral Hemorrhage; Embolization, Therapeutic; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Thromboembolism; Tirofiban; Tyrosine

2012
Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study.
    Cerebrovascular diseases (Basel, Switzerland), 2001, Volume: 12, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Pilot Projects; Platelet Glycoprotein GPIIb-IIIa Complex; Stroke; Tirofiban; Treatment Outcome; Tyrosine

2001

Other Studies

16 other study(ies) available for tirofiban and Cerebral Hemorrhage

ArticleYear
Safety and efficacy of intravenous tirofiban for stent-assisted coiling in acutely ruptured intracranial aneurysms: A single center experience.
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2022, Volume: 28, Issue:4

    Topics: Aneurysm, Ruptured; Cerebral Hemorrhage; Embolization, Therapeutic; Humans; Intracranial Aneurysm; Platelet Aggregation Inhibitors; Retrospective Studies; Stents; Thromboembolism; Tirofiban; Treatment Outcome

2022
Effect of Tirofiban on new cerebral microbleeds after mechanical thrombectomy in patients with acute ischemic stroke.
    Revista da Associacao Medica Brasileira (1992), 2021, Volume: 67, Issue:11

    Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombectomy; Tirofiban; Treatment Outcome

2021
Effect of tirofiban in treating patients with progressive ischemic stroke.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:6

    Topics: Cerebral Hemorrhage; Humans; Ischemic Stroke; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tirofiban; Treatment Outcome

2022
Influence of tirofiban on stroke outcome after mechanical thrombectomy in acute vertebrobasilar artery occlusion.
    BMC neurology, 2022, Dec-09, Volume: 22, Issue:1

    Topics: Arterial Occlusive Diseases; Arteries; Brain Ischemia; Cerebral Hemorrhage; Hospital Mortality; Humans; Ischemic Stroke; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome

2022
Effects of Antecedent Intravenous Thrombolysis on Endovascular Treatment of Acute Stroke Using Tirofiban.
    Journal of vascular and interventional radiology : JVIR, 2023, Volume: 34, Issue:3

    Topics: Brain Ischemia; Cerebral Hemorrhage; Fibrinolytic Agents; Humans; Ischemic Stroke; Stroke; Thrombolytic Therapy; Tirofiban; Treatment Outcome

2023
Association of tirofiban with improvement of functional outcomes of direct thrombectomy for acute anterior circulation occlusion: a retrospective, nonrandomized, multicenter, real-world study.
    Neurosurgical focus, 2023, Volume: 55, Issue:4

    Topics: Brain Ischemia; Cerebral Hemorrhage; Endovascular Procedures; Humans; Ischemic Stroke; Male; Retrospective Studies; Stroke; Thrombectomy; Tirofiban; Treatment Outcome

2023
Increased Rates of Hemorrhages after Endovascular Stroke Treatment with Emergency Carotid Artery Stenting and Dual Antiplatelet Therapy.
    Cerebrovascular diseases (Basel, Switzerland), 2021, Volume: 50, Issue:2

    Topics: Aged; Aged, 80 and over; Carotid Stenosis; Cerebral Hemorrhage; Dual Anti-Platelet Therapy; Emergencies; Endovascular Procedures; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Stroke; Thrombectomy; Thrombolytic Therapy; Time Factors; Tirofiban; Treatment Outcome

2021
Low-Dose Tirofiban Improves Functional Outcome in Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy.
    Stroke, 2017, Volume: 48, Issue:12

    Topics: Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Endpoint Determination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Registries; Risk Factors; Stroke; Thrombectomy; Tirofiban; Treatment Outcome; Tyrosine

2017
Safety and preliminary efficacy of intravenous tirofiban in acute ischemic stroke patient without arterial occlusion on neurovascular imaging studies.
    Journal of the neurological sciences, 2017, Dec-15, Volume: 383

    Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Brain; Brain Ischemia; Cerebral Angiography; Cerebral Hemorrhage; Computed Tomography Angiography; Diffusion Magnetic Resonance Imaging; Female; Fibrinolytic Agents; Humans; Incidence; Male; Middle Aged; Proof of Concept Study; Stroke; Time Factors; Time-to-Treatment; Tirofiban; Treatment Outcome; Tyrosine

2017
Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms.
    Stroke and vascular neurology, 2019, Volume: 4, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cerebral Hemorrhage; Databases, Factual; Dual Anti-Platelet Therapy; Embolization, Therapeutic; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Time Factors; Tirofiban; Treatment Outcome; Young Adult

2019
Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome.
    Stroke, 2013, Volume: 44, Issue:5

    Topics: Aged; Aged, 80 and over; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Risk; Stroke; Thrombectomy; Tirofiban; Tyrosine

2013
A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury.
    British journal of pharmacology, 2015, Volume: 172, Issue:15

    Topics: Animals; Bleeding Time; Blood Platelets; Brain Ischemia; Cell Count; Cerebral Hemorrhage; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrin; Infarction, Middle Cerebral Artery; Lectins, C-Type; Male; Mice; Platelet Glycoprotein GPIb-IX Complex; Protective Agents; Reperfusion Injury; Stroke; Tirofiban; Tyrosine; von Willebrand Factor

2015
Ventriculostomy-Related Hemorrhage After Treatment of Acutely Ruptured Aneurysms: The Influence of Anticoagulation and Antiplatelet Treatment.
    World neurosurgery, 2015, Volume: 84, Issue:6

    Topics: Acute Disease; Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Heparin, Low-Molecular-Weight; Humans; Hydrocephalus; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Thromboembolism; Ticlopidine; Tirofiban; Tyrosine; Ventriculostomy

2015
Safety and Efficacy of Intravenous Tirofiban as Antiplatelet Premedication for Stent-Assisted Coiling in Acutely Ruptured Intracranial Aneurysms.
    AJNR. American journal of neuroradiology, 2016, Volume: 37, Issue:3

    Topics: Administration, Intravenous; Aged; Aneurysm, Ruptured; Cerebral Hemorrhage; Embolization, Therapeutic; Female; Humans; Intracranial Aneurysm; Male; Middle Aged; Platelet Aggregation Inhibitors; Premedication; Retrospective Studies; Stents; Thromboembolism; Tirofiban; Tyrosine

2016
Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Neuroradiology, 2011, Volume: 53, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Angiography; Brain Ischemia; Cerebral Hemorrhage; Combined Modality Therapy; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Injections, Intra-Arterial; Injections, Intravenous; Male; Middle Aged; Recovery of Function; Retrospective Studies; Stroke; Thrombolytic Therapy; Tirofiban; Tissue Plasminogen Activator; Treatment Outcome; Tyrosine; Urokinase-Type Plasminogen Activator

2011
Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative.
    Circulation, 2006, Sep-26, Volume: 114, Issue:13

    Topics: Acute Disease; Adult; Angina, Unstable; Blood Transfusion; Cerebral Hemorrhage; Creatinine; Disease Susceptibility; Dose-Response Relationship, Drug; Eptifibatide; Glomerular Filtration Rate; Hemorrhage; Hemorrhagic Disorders; Humans; Kidney Diseases; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Registries; Sex Characteristics; Tirofiban; Tyrosine

2006